19.08.2019 • NewsOqemachemicals distributionM%26A

Chemical Distributor Oqema Acquires Irish Rocara Group

German Oqema group acquired Irish chemical distributor and manufacturer Rocara....
German Oqema group acquired Irish chemical distributor and manufacturer Rocara. © Getty Images

Mönchengladbach, Germany-headquartered Oqema group acquired Irish chemical distributor and manufacturer Rocara. With operations in Belfast, Northern Ireland, and Dublin, Republic of Ireland, the Rocara group offers a wide range of general and specialty chemicals, solvents and surfactants.

Rob Moss, managing director of Oqema UK, said: “We are very pleased to be welcoming the Rocara companies into the Oqema group. This acquisition supports our business in so many ways. The surfactants help consolidate our personal and home care business whilst the solvents are a natural extension of our existing business. On top of this, we now have a strategic foothold on the island of Ireland for the progression of the Oqema business.”

Rocara will initially continue to operate under its existing brand with Karl Carpenter and Jonathan Morrow, its founders, remaining with the company. They commented: “We are both delighted with the sale of our group of companies to Oqema which opens up wonderful opportunities for both our suppliers and customers and future proofs our company within the Oqema Group.”

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.